Human T-cell leukemia virus type I-associated myelopathy following living-donor liver transplantation. [electronic resource]
- Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society May 2008
- 647-50 p. digital
Publication Type: Case Reports; Journal Article
1527-6473
10.1002/lt.21414 doi
Antiviral Agents--therapeutic use Drug Therapy, Combination Gait Disorders, Neurologic--etiology Graft Rejection--prevention & control Hepatitis C--complications Humans Immunosuppressive Agents--therapeutic use Interferon alpha-2 Interferon-alpha--therapeutic use Liver Cirrhosis--surgery Liver Transplantation--adverse effects Living Donors Male Middle Aged Paraparesis, Tropical Spastic--complications Recombinant Proteins Steroids--therapeutic use Tacrolimus--therapeutic use Treatment Outcome Urination Disorders--etiology